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Background: Implants and drugs with animal and human derived content are widely used in medicine and
surgery, but information regarding ingredients is rarely obtainable by health practitioners. A religious perspective
concerning the use of animal and human derived drug ingredients has not thoroughly been investigated. The
purpose of this study was to clarify which parts of the medical and surgical treatments offered in western
world-hospitals that conflicts with believers of major religions.
Methods: Religious and spiritual leaders of the six largest religions worldwide (18 branches) were contacted. A
standardised questionnaire was sent out regarding their position on the use of human and animal derived products
in medical and surgical treatments.
Results: Of the 18 contacted religious branches, 10 replied representing the 6 largest religions worldwide. Hindus
and Sikhs did not approve of the use of bovine or porcine derived products, and Muslims did not accept the use
of porcine derived drugs, dressings or implants. Christians (including Jehovah’s Witnesses), Jews and Buddhists
accepted the use of all animal and human derived products. However, all religions accepted the use of all these
products in case of an emergency and only if alternatives were not available.
Conclusions: The views here suggest that religious codes conflict with some treatment regimens. It is crucial to
obtain informed consent from patients for the use of drugs and implants with animal or human derived content.
However, information on the origin of ingredients in drugs is not always available to health practitioners.Background
Rules and customs regarding consumption and use of
specific animals differ among different religious branches.
Religious beliefs potentially conflict with specific health
care situations in cases of removing a patient from ventila-
tor support (Orthodox Jews), blood transfusions (Jehovah’s
Witnesses), fluid and nutrition therapy (Roman Catholics)
and ending life in patients with documented brain death
(Buddhists) [1-3].
In modern medicine, animal derived products are used
in many fields, e.g. anaesthesiology, psychiatry, ortho-
paedic, plastic and general surgery [3-8], which potentially
can create conflicts with religious beliefs. No centralized
information is available for either patients or physicians
regarding animal derived ingredients in drugs, implants or
dressings [5,9-11]. In cases of conflicts between religious
beliefs and needed treatment, a risk of non-adherence is* Correspondence: axelinae@gmail.com
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reproduction in any medium, provided the orpresent [12]. This problem of animal derived ingredients
in drugs has been addressed several times in the literature
across specialties [2-6,8,10,12-15].
The purpose of this study was to clarify which major reli-
gious beliefs that potentially are in conflict with medical or
surgical treatments that contain animal derived products.Methods
Religious branches exceeding more than 15 million adhe-
rents worldwide were included as potential participants
in this study [16] (Table 1). The major Christian bran-
ches (Catholicism, Orthodoxies, liberal and conservative
Protestantism, African indigenous sects, Pentecostalism,
Jehovah’s Witnesses and the Anglican Church), the
Muslim branches (Sunni and Shiite), the Hindu branches
(Vaishnavism, Shavites, and Neo-hindus) and the Buddhist
branches (Mahayana, Theravada, and Lamaism) were
pooled for each religion (see Table 1).
A questionnaire was designed and face validated [17].
It consisted of 7 questions concerning the religion’sl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Number of adherents for religious branches
exceeding more than 15 million adherents
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bovine content in drugs, dressings and implants was
allowed for adherents of their respective religion. For
each question, an example was stated. Drugs used as
examples are shown in Table 2. We found this method
the most valid, compared to searching texts and state-
ments. The specific information was either not acces-
sible, or could be interpreted differently, or the validity
of these texts were meant for a limited group of people
in a specific context. The purpose of the study, was
emailed to selected religious leaders in 26 different
countries (Denmark, Sweden, Germany, United Kingdom,
Hungary, Russia, Italy, Greece, USA, Thailand, Malaysia,
Nepal, China, India, Lebanon, Iran, Turkey, Serbia,
Poland, Belarus, Bangladesh, Sri Lanka, Egypt, Kenya,
Syria and Mongolia), which were discovered through
homepages of religious branches in the countries where
the religion was dominant. If no answer was received by
email the religious leaders were contacted via telephone
through their organisation and offered the opportunity to
answer the questionnaire orally. It was beyond the scopeTable 2 An arbitrary example of well-known drugs with anim
information is not obtainable, to make a full list
Type Examples
Drugs Amoxycillin, omeprazole, warfarin, prednis
Dressings Hydrocolloids, split skin graft
Surgical products/implants Mesh, bone, orthopaedic spacer, matrix hof our study to investigate the physician’s attitude towards
the use of drugs and implants with potential animal
derived content. There may be other perspectives, than
religious, for a person to object to animal-derived treat-
ments. These groups and their beliefs were not addressed
in this study.
There were no conflicts of interest and there was no
need for any ethics committees’ permission, which they
confirmed, since it the included subjects only were sta-
ting the general position for their branch of religion. AE,
JB and JR developed the concept, design and disposition
for the study. The questionnaire was developed by AE,
JB and JR. AE contacted religious and spiritual leaders
and analysed the data with JB and JR. The first manu-
script draft was written by AE and revised critically by
JB and JR. All authors have read and approved the final
manuscript.
The drugs used as examples were arbitrarily selected,
to be well known drugs where it was possible find the
origin of the contents [18,19]. Information on the
chosen drugs with animal derived contents was found
through the Danish Medicines Agency [18]. Information
on dressings and implants were found in the PubMed
database.
Results
Of the 18 contacted religious branches, 10 replied,
representing the 6 largest religions worldwide (see
Table 3). The major branch of Hinduism, Vaishnavism,
did not permit the use of any drugs, dressings or
implants, if they contained porcine or bovine material,
since they considered killing of animals and especially
the killing of cows, sinful. Sikhs did not approve of any
use of animal derived products. However, in emergency
or starvation situations, those rules could be waived for
both Hindus and Sikhs. Even in routine treatment, if
patients were lacking reasonable alternatives drugs,
bandages or implants containing animal products could
be allowed. All such decisions were left to be decided by
the individual.
We found that Sunni and Shiite Muslims did not
approve of drugs, dressings or implants with porcine
content. However, as for Hindus and Sikhs these products
were allowed, if no other alternative drug existed and the
treatment was considered life prolonging. In an emergency
situation the use of these drugs was also approved. Sunnial or human derived ingredients, since the full product
Porcine Bovine Human
olone, oxinorm, heparin X x
X x x
aemostasis X x x
Table 3 Replies from religious branches, indicating which products that are allowed, and not














Christianity (Catholics, Protestants, African indigenous
sects and Jehovah’ Witnesses)
Yes Yes Yes Yes Yes Yes Yes2
Islam (Sunni and Shiite) No1 Yes No1 Yes No1 Yes Yes
Hindu (Vaishnavism) No1 No1 No1 No1 No1 No1 Yes2
Buddhism (Theravada) Yes Yes Yes Yes Yes Yes Yes
Sikhism No1 No1 No1 No1 No1 No1 Yes
Judaism Yes Yes Yes Yes Yes Yes Yes2
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no alternative treatment was available, since human life is
considered more sacred than the haram (forbidden) use of
porcine.
Christians (including Jehovah’s Witnesses), Theravada
Buddhists and Jews had no problem with the use of drugs,
dressings or implants with animal or human derived
contents. Christians (including Jehovah’s Witnesses), Hindus
and Sikhs, commented that the use of human derived
implants were only allowed if a donor had given consent.
Jehovas Witnesses commented that only the use of blood
derived products was forbidden.
Discussion
The basic findings of the study were that among the
largest (by number of adherents worldwide) religious
branches, several of them had restrictions regarding the
use of animal derived medical products. Hindus and Sikhs
did not accept the use of bovine or porcine containing
products, and Muslims did not accept the use of por-
cine drugs, dressings or implants. Christians, Jehovah’s
Witnesses, Jews and Buddhists accepted the use of all
animal or human derived drugs, dressings and implants.
Interestingly, all religions accepted the use of animal
derived products if there were no alternatives or if they
were used in an emergency situation.
It is widely accepted that clinicians must inform patients
and get consent for each component within a treatment
plan [20]. This ethical aspect is considered so crucial that
it has become obliged by law in Denmark [21] how this
information should be passed on to the patient, is yet to find
out. It could be written in the product information, however
at the moment it is not possible for the physician to inform
the patient since the information is not accessible [22].
To establish whether a drug has animal origin or con-
tent, it is possible to contact the manufacturer or a
national medicines agency [23]. However, the origin of the
ingredients is not always obvious. Examples of drugs with
animal derived excipients are shown in Table 2. It is
known that gelatine is of animal (porcine or bovine) origin
and it has earlier been shown that 50-80% of all capsules
contain gelatine [24]. An example of a widespread soldcapsule-drug is the proton pump inhibitor omeprazole
(Actavis Group, Iceland; Bluefish, Sweden; BMM Pharma,
Sweden; Copyfarm, Denmark; Pensa Pharma, Sweden;
Recept Pharma, Sweden; Sandoz, Switzerland; Stada,
Germany; and many more) [25]. Twelve out of 14 available
omeprazole alternatives on the Danish market alone con-
tain gelatine, which in up to 80% of the cases is derived
from pigs [18,24].
The extent of the use of animal derived exipients in
drugs has previously been addressed in a study from the
United States. They found that 15 out of 41 psychotropic
medications contained gelatine [3]. All but one heparin-
drugs in the UK originated from animals, and the syn-
thetic alternative was not approved for surgeries other
than orthopaedic procedures [23]. Furthermore, measles,
mumps and rubella vaccines and tablets containing
pancreatic enzymes were of animal origin [23].
The use of the use of biological dressings in the treat-
ment of chronic and acute wounds including burns, was
discussed in one previous article [26]. Split skin grafts
from a donor and dressings derived from animals can be
used instead of allo-transplanted skin. The use of these
alternative products avoids the donor-site problem on
the patient, and animal derived dressings are easier to
acquire. These products may be better in certain circum-
stances compared with synthetic alternatives [26,27].
Hydrocolloids act by autolysis, rehydrating the wound
and thereby promote debridement [5,26]. A study found
that a majority of healthcare professionals in the UK did
not know the origin of animal derived products in
frequently used dressings [5]. The same study found that
use of porcine and bovine dressings, in adherents of the
Chinese society, Jehovah’s Witnesses, Methodists and
Muslims, required informed consent for some reason,
not stated. Dressings derived from humans used in
adherents to the Anglican Church, Jehovah’s Witnesses,
Methodists, Quakers, Roman Catholics and Salvation
Army, required informed consent [5].
Implants are surgical products left in the body e.g.
heart valves, meshes used for hernia repair, and spacers
used in orthopaedic surgery. These products are more
thoroughly labelled than drugs. The use of biological
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tion, and are overall better integrated with less postsur-
gical pain and discomfort compared with their synthetic
alternatives [28,29]. The religious aspects on the use of
biological meshes in comparison with the religious food
restrictions were investigated in a previously published
study [6]. Representatives from Judaism, Islam, Buddhism,
Hinduism, Scientology and several branches of Christianity
had no objections on the use of biological meshes. The
Church of Jesus Christ of Latter Days Saints felt the need
for informed consent for the use of these types of meshes,
and the study also found that religious food restrictions did
not translate into restrictions in the surgical field. Another
study on biological implants and animal derived drugs used
in orthopaedic surgery sought guidelines from religious
leaders in Australia [7] and found that Hindus did not
accept the use of bovine surgical implants, where Muslims
permitted the use of porcine surgical products if all other
options had been exhausted. Their results differ somewhat
from the results in the current article.
In comparison to the present study, previous studies
have not focused on world-wide religions, but the most
popular religions in their respective countie. The main
focus of earlier published studies was to examine
whether followers of religious groups would like infor-
mation on the origin of products. In this study, it was
assumed that informed consent should be obtained for
the use of these types of products, but the aim was to
investigate where the conflicts may appear. Dietary
restrictions were not relevant for us when addressing
this matter and therefore it did not bias the selection of
religions or its outcome. Furthermore, previous studies
have investigated the issue in a narrow perspective,
concerning only one speciality, one country or not cove-
ring drugs with animal origin. Therefore, it was not
possible to compare previous studies to the present.
Alternative drugs, dressings or implants without
human or animal derived content exist, however not for
all products [4,23]. Knowledge of these alternatives is
crucial for health practitioners in order to properly guide
their patients of Hindu, Sikh or Muslim faith. Therefore,
the health practitioner should both have sufficient know-
ledge on drug and implant ingredients and religious
considerations of the treatment regimens.
A limitation of this study was that individual differences
in the interpretation of the religion must be considered.
The contacted religious leaders were asked to reply on
behalf of their adherents, but that does not translate into
all adherents having exact the same religious standpoint
as that particular spiritual leader. Thus, some Hindus,
Muslims and Sikhs may not have a negative standpoint
towards animally derived products. Neither does this study
conclude that all Christians, Buddhists and Jews accept all
of these products and does not want to be informed aboutthe origin of animal derived origin of drugs, dressings or
implants.
Conclusions
In conclusion, it is necessary to obtain informed consent
for the use of animal or human derived products for
several religions, since they may oppose to the treat-
ment. Hindus, Sikhs and Muslims, do not approve of
some animal derived products if there are other alterna-
tives. However, if there are no alternatives, and if the
treatment is life-saving, then all religions approved of all
treatment modalities regardless of origin.
1. They accepted the use of all animal and human
derived products, in case of emergency and only if
other alternatives were not available.
2. Religious leaders commented that the donor must
have given informed consent.
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